Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine
Historical observation
20182026
Universe›Health Care›Biotechnology›Biotechnology
Biotechnology · weight
2.70%
Industry change · 12M
-0.49 pp
Biotechnology · contribution
-0.495 pp
Company participation
100%
of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Mar 2019 · sorted by absolute contribution to 12-month change

CompanyCountryMarket capUniverse weight3M contribution12M contribution12M price returnAbove 6M weight average
AbbVie →
ABBV
United States$118.9bn0.683%+0.187 pp-0.239 pp-11.1%Yes
Gilead Sciences →
GILD
United States$82.9bn0.476%+0.187 pp-0.130 pp-10.8%Yes
Biogen →
BIIB
United States$46.5bn0.267%+0.050 pp-0.088 pp-13.7%Yes
Amgen →
AMGN
United States$118.2bn0.679%+0.236 pp-0.075 pp+14.7%Yes
Regeneron Pharmaceuticals →
REGN
United States$38.6bn0.222%+0.096 pp+0.023 pp+19.2%Yes
Vertex Pharmaceuticals →
VRTX
United States$47.0bn0.270%+0.119 pp+0.016 pp+12.9%Yes
Incyte →
INCY
United States$18.4bn0.106%+0.057 pp-0.002 pp+3.2%Yes

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.